Spineguard (XPAR:ALSGD) Receivables Turnover: 2.10 (As of Dec. 2025)


What is Spineguard Receivables Turnover?

Spineguard XPAR:ALSGD +1.83% Receivables Turnover is 2.10 as of Dec. 2025. The stock has 4 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Spineguard ranks worse than 55.98% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Spineguard's Revenue for the six months ended in Dec. 2025 was €1.64 Mil. Spineguard's average Accounts Receivable for the six months ended in Dec. 2025 was €0.78 Mil. Hence, Spineguard's Receivables Turnover for the six months ended in Dec. 2025 was 2.10.


Spineguard  (XPAR:ALSGD) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Spineguard Receivables Turnover Related Terms


Spineguard Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Spineguard's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spineguard Receivables Turnover Chart

Spineguard Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.59 6.51 4.68 6.77 6.28

Spineguard Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.68 2.73 2.64 2.63 2.10

XPAR:ALSGD vs ABT, SYK, MDT: Receivables Turnover Comparison

For the Medical Devices subindustry, Spineguard's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spineguard Receivables Turnover vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Spineguard's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Spineguard's Receivables Turnover falls into.



Spineguard Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Spineguard's Receivables Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Receivables Turnover (A: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2025 ) / ((Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count )
=3.757 / ((0.626 + 0.571) / 2 )
=3.757 / 0.5985
=6.28

Spineguard's Receivables Turnover for the quarter that ended in Dec. 2025 is calculated as

Receivables Turnover (Q: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Dec. 2025 ) / ((Accounts Receivable (Q: Jun. 2025 ) + Accounts Receivable (Q: Dec. 2025 )) / count )
=1.637 / ((0.986 + 0.571) / 2 )
=1.637 / 0.7785
=2.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 2.10 mean?
Spineguard (XPAR:ALSGD) has a Receivables Turnover of 2.10 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Spineguard and its competitors. According to the industry distribution chart, Spineguard ranks #454 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 56%.
Is Spineguard's Receivables Turnover too high?
Spineguard's current Receivables Turnover is 2.10. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Spineguard's value of 2.10 is 61.9% below this industry median. Based on the distribution chart, Spineguard ranks #454 out of 811 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Spineguard's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Spineguard ranks #454 out of 811 companies for Receivables Turnover. This places Spineguard in the lower half of its industry. The industry median Receivables Turnover is 5.51. Spineguard's value of 2.10 is 61.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spineguard's current Receivables Turnover of 2.10 is 61.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Spineguard and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spineguard's current Receivables Turnover is 2.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spineguard stock overvalued right now?
Based on GuruFocus' analysis, Spineguard (XPAR:ALSGD) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.10, compared to a current price of €0.08 — trading 16.5% below its estimated fair value. The current Receivables Turnover is 2.10 and 61.9% below the Medical Devices & Instruments industry median of 5.51. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Spineguard (XPAR:ALSGD), the current Receivables Turnover is 2.10 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Spineguard Business Description

Other Exchanges 6W5:Germany
Address 10 Cours Louis Lumiere, Vincennes, FRA, 94300
Spineguard is engaged in the design and production of medical instruments used for spinal surgeries. It is deploying its proprietary radiation-free real time sensing technology DSG (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. It designs, develops and markets medical devices embedding its technology. The group is developing DSG digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and smart drills. SpineGuard is extending the applications of its DSG technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.